BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 21873975)

  • 1. Signalling pathway for RKIP and Let-7 regulates and predicts metastatic breast cancer.
    Yun J; Frankenberger CA; Kuo WL; Boelens MC; Eves EM; Cheng N; Liang H; Li WH; Ishwaran H; Minn AJ; Rosner MR
    EMBO J; 2011 Aug; 30(21):4500-14. PubMed ID: 21873975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RKIP and HMGA2 regulate breast tumor survival and metastasis through lysyl oxidase and syndecan-2.
    Sun M; Gomes S; Chen P; Frankenberger CA; Sankarasharma D; Chung CH; Chada KK; Rosner MR
    Oncogene; 2014 Jul; 33(27):3528-37. PubMed ID: 23975428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Raf kinase inhibitory protein suppresses a metastasis signalling cascade involving LIN28 and let-7.
    Dangi-Garimella S; Yun J; Eves EM; Newman M; Erkeland SJ; Hammond SM; Minn AJ; Rosner MR
    EMBO J; 2009 Feb; 28(4):347-58. PubMed ID: 19153603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RKIP Inhibits Local Breast Cancer Invasion by Antagonizing the Transcriptional Activation of MMP13.
    Datar I; Feng J; Qiu X; Lewandowski J; Yeung M; Ren G; Aras S; Al-Mulla F; Cui H; Trumbly R; Arudra SK; De Las Casas LE; de la Serna I; Bitar MS; Yeung KC
    PLoS One; 2015; 10(8):e0134494. PubMed ID: 26308852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RKIP suppresses the proliferation and metastasis of breast cancer cell lines through up-regulation of miR-185 targeting HMGA2.
    Zou Q; Wu H; Fu F; Yi W; Pei L; Zhou M
    Arch Biochem Biophys; 2016 Nov; 610():25-32. PubMed ID: 27651238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-224 targets RKIP to control cell invasion and expression of metastasis genes in human breast cancer cells.
    Huang L; Dai T; Lin X; Zhao X; Chen X; Wang C; Li X; Shen H; Wang X
    Biochem Biophys Res Commun; 2012 Aug; 425(2):127-33. PubMed ID: 22809510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prognostic gene signature for metastasis-free survival of triple negative breast cancer patients.
    Lee U; Frankenberger C; Yun J; Bevilacqua E; Caldas C; Chin SF; Rueda OM; Reinitz J; Rosner MR
    PLoS One; 2013; 8(12):e82125. PubMed ID: 24349199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metastasis Suppressors Regulate the Tumor Microenvironment by Blocking Recruitment of Prometastatic Tumor-Associated Macrophages.
    Frankenberger C; Rabe D; Bainer R; Sankarasharma D; Chada K; Krausz T; Gilad Y; Becker L; Rosner MR
    Cancer Res; 2015 Oct; 75(19):4063-73. PubMed ID: 26238785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Raf kinase inhibitory protein (RKIP) as a metastasis suppressor: regulation of signaling networks in cancer.
    Yesilkanal AE; Rosner MR
    Crit Rev Oncog; 2014; 19(6):447-54. PubMed ID: 25597354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polycomb protein EZH2 regulates tumor invasion via the transcriptional repression of the metastasis suppressor RKIP in breast and prostate cancer.
    Ren G; Baritaki S; Marathe H; Feng J; Park S; Beach S; Bazeley PS; Beshir AB; Fenteany G; Mehra R; Daignault S; Al-Mulla F; Keller E; Bonavida B; de la Serna I; Yeung KC
    Cancer Res; 2012 Jun; 72(12):3091-104. PubMed ID: 22505648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of RKIP inhibits cell invasion in glioma cell lines through upregulation of miR-98.
    Chen Z; Cheng Q; Ma Z; Xi H; Peng R; Jiang B
    Biomed Res Int; 2013; 2013():695179. PubMed ID: 24392454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of the epithelial to mesenchymal transition and metastasis by Raf kinase inhibitory protein-dependent Notch1 activity.
    Noh HS; Hah YS; Ha JH; Kang MY; Zada S; Rha SY; Kang SS; Kim HJ; Park JY; Byun JH; Hahm JR; Shin JK; Jeong SH; Lee YJ; Kim DR
    Oncotarget; 2016 Jan; 7(4):4632-46. PubMed ID: 26716415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Network of mutually repressive metastasis regulators can promote cell heterogeneity and metastatic transitions.
    Lee J; Lee J; Farquhar KS; Yun J; Frankenberger CA; Bevilacqua E; Yeung K; Kim EJ; Balázsi G; Rosner MR
    Proc Natl Acad Sci U S A; 2014 Jan; 111(3):E364-73. PubMed ID: 24395801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-543 Promotes Proliferation and Epithelial-Mesenchymal Transition in Prostate Cancer via Targeting RKIP.
    Du Y; Liu XH; Zhu HC; Wang L; Ning JZ; Xiao CC
    Cell Physiol Biochem; 2017; 41(3):1135-1146. PubMed ID: 28245474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Raf kinase inhibitor protein (RKIP) in cancer.
    Escara-Wilke J; Yeung K; Keller ET
    Cancer Metastasis Rev; 2012 Dec; 31(3-4):615-20. PubMed ID: 22684368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Raf kinase inhibitor protein suppresses nuclear factor-κB-dependent cancer cell invasion through negative regulation of matrix metalloproteinase expression.
    Beshir AB; Ren G; Magpusao AN; Barone LM; Yeung KC; Fenteany G
    Cancer Lett; 2010 Dec; 299(2):137-49. PubMed ID: 20855151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RKIP regulates CCL5 expression to inhibit breast cancer invasion and metastasis by controlling macrophage infiltration.
    Datar I; Qiu X; Ma HZ; Yeung M; Aras S; de la Serna I; Al-Mulla F; Thiery JP; Trumbly R; Fan X; Cui H; Yeung KC
    Oncotarget; 2015 Nov; 6(36):39050-61. PubMed ID: 26375811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The RhoA dependent anti-metastatic function of RKIP in breast cancer.
    Kalpana G; Figy C; Feng J; Tipton C; De Castro JN; Bach VN; Borile C; LaSalla A; Odeh HN; Yeung M; Garcia-Mata R; Yeung KC
    Sci Rep; 2021 Aug; 11(1):17455. PubMed ID: 34465801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of RKIP, STAT3 and cyclin D1 expression in pathogenesis of gastric cancer.
    Zhang XM; Zhou C; Gu H; Yan L; Zhang GY
    Int J Clin Exp Pathol; 2014; 7(9):5902-8. PubMed ID: 25337233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of novel metastasis suppressor signaling pathways for breast cancer.
    Minn AJ; Bevilacqua E; Yun J; Rosner MR
    Cell Cycle; 2012 Jul; 11(13):2452-7. PubMed ID: 22659842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.